Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of Atopic Dermatitis rated at least mild using the Investigator's Global Atopic Dermatitis Assessment involving a minimum of 5% of the body surface area
Negative pregnancy test and agrees to practice effective birth control during the study
You may not be if
Skin disorder other than Atopic Dermatitis in the areas to be treated
Extensive scarring or pigmented lesions in the areas to be treated that would interfere with rating of efficacy parameters
Clinically infected Atopic Dermatitis at baseline
Likely to require systemic corticosteroids; or likely to require intranasal or inhaled corticosteroids for an off-label indication or at higher doses than the maximum labeled dosing for the drug
Known hypersensitivity to macrolides or any excipient of either study medication
Chronic condition which is either not stable or not well controlled
Pregnant or breast feeding an infant
Clareo Health | A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis
